# Brady Corp: Form 10-Q for the period ended Apr 30, 2020

- Company: [Brady Corp](/companies/brc.md) (CIK 746598)
- Form: 10-Q
- Filed: 2020-05-21
- Accepted by EDGAR: May 21, 2020, 07:17 ET
- Period: 2020-04-30
- Accession: 0000746598-20-000048
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/746598/000074659820000048/brc-20200430.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/746598/000074659820000048/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-04-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2020-02-01 to 2020-04-30 | $136.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-08-01 to 2020-04-30 | $419.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-02-01 to 2020-04-30 | $129.5m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-08-01 to 2020-04-30 | $410.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-02-01 to 2020-04-30 | $9.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2019-08-01 to 2020-04-30 | $31.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-02-01 to 2020-04-30 | $83.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2019-08-01 to 2020-04-30 | $260.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-02-01 to 2020-04-30 | $22.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-08-01 to 2020-04-30 | $104.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-02-01 to 2020-04-30 | $628.0k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-08-01 to 2020-04-30 | $2.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-02-01 to 2020-04-30 | $8.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-08-01 to 2020-04-30 | $21.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-02-01 to 2020-04-30 | $13.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-08-01 to 2020-04-30 | $84.7m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2020-02-01 to 2020-04-30 | 52,972,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-08-01 to 2020-04-30 | 53,512,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-08-01 to 2020-04-30 | $95.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-08-01 to 2020-04-30 | $21.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2019-08-01 to 2020-04-30 | $34.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2019-08-01 to 2020-04-30 | $64.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-04-30 | $238.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-04-30 | $531.1m | us-gaap:AssetsCurrent |
| Total assets | at 2020-04-30 | $1.14bn | us-gaap:Assets |
| Current liabilities | at 2020-04-30 | $228.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-04-30 | $319.7m | us-gaap:Liabilities |
| Current portion of debt | at 2020-04-30 | $48.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2020-04-30 | $820.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,061 characters.

#### Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative identification and healthcare products. The WPS segment provides workplace safety and compliance products, approximately half of which are internally manufactured and half of which are externally sourced.

The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve operational excellence, focus on the customer, develop and market innovative new products, and to advance our digital capabilities. In our Identification Solutions ("ID Solutions" or "IDS") business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and investing in research and development ("R&D") to develop new products. In our Workplace Safety ("WPS") business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, compliance expertise, customization expertise, and improving our digital capabilities.

The Company’s key initiatives for 2020 have not changed, however, the respective business plans to achieve these key initiatives have been and are expected to continue to be affected by the COVID-19 pandemic.

Our key initiatives supporting our strategy in fiscal 2020 are focused on:

- Investing in organic growth by enhancing our research and development process and improving the time to launch high-value, innovative products in alignment with our target markets.
- Providing our customers with the highest level of customer service.
- Expanding and enhancing our sales capabilities through an improved digital presence and increased sales resources.
- Driving operational excellence and executing sustainable efficiency gains within our global operations and within our selling, general and administrative structures.
- Growing through focused actions in selected vertical markets and strategic accounts.
- Enhancing our employee development process to create an engaged workforce and to attract and retain key talent.

#### Impact of the COVID-19 Pandemic on Our Business

The impact of the COVID-19 pandemic on the global economic environment has resulted in reduced demand across the majority of our end markets. In the near-term, the COVID-19 pandemic is expected to have adverse effects on our sales, overall profitability, and working capital. As of the date of this filing, significant uncertainty exists concerning the magnitude of the impact and duration of the COVID-19 pandemic.

Brady Corporation is deemed an essential business under the majority of local government orders. Our products support first responders, healthcare workers, food processing companies, and many other critical industries. Certain of our businesses were shutdown temporarily during the quarter ended April 30, 2020, which had an impact on our financial results and operations. However, the majority of our facilities were operating globally while implementing enhanced safety protocols designed to protect the well-being of our employees.

We are taking actions throughout our business to reduce controllable costs, including reductions in labor costs, eliminating non-essential travel, and reducing discretionary spend. We believe we have the financial strength to continue to invest in organic sales growth opportunities and R&D, while continuing to drive efficiencies and automation in our operations and selling, general and administrative expenses ("SG&A") functions. At April 30, 2020, we have cash of $238.9 million, current maturities on long-term debt of $48.9 million and an undrawn credit facility of $200 million, for total liquidity of approximately $390 million.

Due to the speed with which the COVID-19 pandemic has developed and the resulting uncertainty, including the depth and duration of any disruptions to customers and suppliers, its future effect on our business, results of operations, and financial condition cannot be predicted. Despite this uncertainty, we believe that our financial resources and liquidity levels, along with various contingency plans to reduce costs are sufficient to manage the impact of the COVID-19 pandemic, which may result in reduced sales, net income and operating cash flows. Refer to Risk Factors, included in Part II, Item 1A of this Quarterly Report on Form 10-Q, for further discussion of the possible impact of the COVID-19 pandemic on our business.

#### Results of Operations

A comparison of results of operating income for the three and nine months ended April 30, 2020 and 2019, is as follows:

*(Dollars in thousands)*

|  | Three months ended April 30, 2020 | % Sales | 2019 | % Sales | Nine months ended April 30, 2020 | % Sales | 2019 | % Sales |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **Net sales** | $265,943 |  | $289,745 |  | $829,555 |  | $865,367 |  |
| **Gross margin** | 129,527 | 48.7% | 145,749 | 50.3% | 410,059 | 49.4% | 432,098 | 49.9% |
| **Operating expenses:** |  |  |  |  |  |  |  |  |
| Research and development | 9,814 | 3.7% | 11,437 | 3.9% | 31,298 | 3.8% | 33,837 | 3.9% |
| Selling, general and administrative | 83,223 | 31.3% | 94,691 | 32.7% | 260,136 | 31.4% | 281,988 | 32.6% |
| Impairment charges | 13,821 | 5.2% | — | —% | 13,821 | 3.4% | — | —% |
| Total operating expenses | 106,858 | 40.2% | 106,128 | 36.6% | 305,255 | 36.8% | 315,825 | 36.5% |
| **Operating income** | $22,669 | 8.5% | $39,621 | 13.7% | $104,804 | 12.6% | $116,273 | 13.4% |

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Sales for the three months ended April 30, 2020, decreased 8.2% to $265.9 million, compared to $289.7 million in the same period of the prior year. The decrease consisted of an organic sales decline of 6.0% and a decrease from foreign currency translation of 2.2%. Organic sales declined 8.2% in the IDS segment and grew 0.2% in the WPS segment during the three months ended April 30, 2020, compared to the same period in the prior year. Organic sales increased by 2.7% through the first two months of the quarter and decreased by 23.6% in the month of April, compared to the same periods in the prior year.

Sales for the nine months ended April 30, 2020, decreased 4.1% to $829.6 million, compared to $865.4 million in the same period of the prior year. The decrease consisted of an organic sales decline of 2.5% and a decrease from foreign currency translation of 1.6%. Organic sales declined 3.2% in the IDS segment and declined 0.5% in the WPS segment during the nine months ended April 30, 2020, compared to the same period in the prior year.

Gross margin decreased 11.1% to $129.5 million and decreased 5.1% to $410.1 million for the three and nine months ended April 30, 2020, respectively, compared to $145.7 million and $432.1 million in the same periods of the prior year. As a percentage of net sales, gross margin decreased to 48.7% and 49.4% for the three and nine months ended April 30, 2020, respectively, compared to 50.3% and 49.9% in the same periods of the prior year. The decrease in gross margin as a percentage of net sales during both the three and nine-month periods was primarily due to the decline in sales volumes resulting from the economic slowdown caused by the COVID-19 pandemic.

R&D expenses decreased 14.2% to $9.8 million and decreased 7.5% to $31.3 million for the three and nine months ended April 30, 2020, respectively, compared to $11.4 million and $33.8 million in the same periods of the prior year. As a percentage of sales, R&D expenses remained consistent for the three and nine months ended April 30, 2020, compared to the same periods of the prior year. The decrease in R&D expenses was primarily due to a reduction in incentive-based compensation in the current three and nine-month periods compared to the same periods in the prior year. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers and materials continue to be the primary focus of R&D expenditures.

SG&A expenses include selling costs directly attributed to the IDS and WPS segments, as well as certain other administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A decreased 12.1% to $83.2 million and 7.7% to $260.1 million for the three and nine months ended April 30, 2020, respectively, compared to $94.7 million and $282.0 million in the same periods of the prior year. As a percentage of sales, SG&A was 31.3% and 31.4% for the three and nine months ended April 30, 2020, respectively, compared to 32.7% and 32.6% in the same periods of the prior year. Increased costs associated with the COVID-19 pandemic during the three-month period, including employee severance and other related costs, were offset by reduced incentive compensation. The decrease in SG&A in the nine-month period was due to ongoing efficiency gains and reduced incentive compensation, and to a lesser extent the impact of foreign currency translation.

As a result of the economic slowdown, management evaluated whether indicators of impairment of intangible assets and other long-lived assets existed as of April 30, 2020. Management concluded that the COVID-19 pandemic resulted in indicators of impairment in certain businesses within the WPS and IDS segments, and performed an interim impairment analysis. As a result of the analysis, impairment charges of $13.8 million related to other intangible and long-lived assets, primarily in the WPS segment, were recorded during the three months ended April 30, 2020. Refer to Note D, "Other Intangible and Long-Lived Assets" for further discussion regarding the impairment charges.

Operating income decreased 42.8% to $22.7 million for the three months ended April 30, 2020, and decreased 9.9% to $104.8 million for the nine months ended April 30, 2020, compared to $39.6 million and $116.3 million in the same periods of the prior year, respectively. The decrease in operating income for both the three and nine-month periods ended April 30, 2020, compared to the same periods in the prior year, was primarily due to impairment charges of $13.8 million recognized in the current quarter.

### OPERATING INCOME TO NET INCOME

*(Dollars in thousands)*

|  | Three months ended April 30, 2020 | % Sales | 2019 | % Sales | Nine months ended April 30, 2020 | % Sales | 2019 | % Sales |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $22,669 | 8.5% | $39,621 | 13.7% | $104,804 | 12.6% | $116,273 | 13.4% |
| Other income (expense): |  |  |  |  |  |  |  |  |
| Investment and other income | 112 | —% | 2,065 | 0.7% | 3,252 | 0.4% | 3,425 | 0.4% |
| Interest expense | (628) | (0.2)% | (708) | (0.2)% | (1,976) | (0.2)% | (2,137) | (0.2)% |
| Income before income tax | 22,153 | 8.3% | 40,978 | 14.1% | 106,080 | 12.8% | 117,561 | 13.6% |
| Income tax expense | 8,520 | 3.2% | 6,197 | 2.1% | 21,396 | 2.6% | 22,916 | 2.6% |
| Net income | $13,633 | 5.1% | $34,781 | 12.0% | $84,684 | 10.2% | $94,645 | 10.9% |

Investment and other income was $0.1 million and $2.1 million for the three months ended April 30, 2020 and 2019, respectively. The decrease in the three-month period was primarily due to a decrease in the market value of securities held in deferred compensation plans. Investment and other income was $3.3 million and $3.4 million for the nine months ended April 30, 2020, and 2019, respectively. The market value of securities held in deferred compensation plans remained essentially flat during the current nine-month period while interest income increased compared to the prior nine-month period. Interest income is expected to decline in future periods considering the recent decline in interest rates.

Interest expense was consistent at $0.6 million and $0.7 million for the three months, and $2.0 million and $2.1 million for the nine months ended April 30, 2020 and 2019, respectively. There was minimal change in the Company's principal balance under its outstanding debt agreements. The Company's income tax rate was 38.5% for the three months ended April 30, 2020, compared to 15.1% for the same period in the prior year. The income tax rate was 20.2% for the nine months ended April 30, 2020, compared to 19.5% for the same period in the prior year. Refer to Note M, " Income Taxes" for additional information on the Company's income tax rates.

#### Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Impairment charges, interest expense, investment and other income, income tax expense, and certain corporate administrative expenses are excluded when evaluating segment performance.

The following is a summary of segment information for the three and nine months ended April 30, 2020, and 2019:

| SALES GROWTH INFORMATION ID Solutions | Three months ended April 30, 2020 | 2019 | Nine months ended April 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Organic | (8.2)% | 4.0% | (3.2)% | 4.4% |
| Currency | (1.5)% | (3.1)% | (1.1)% | (2.3)% |
| Total | (9.7)% | 0.9% | (4.3)% | 2.1% |
| **Workplace Safety** |  |  |  |  |
| Organic | 0.2% | (1.6)% | (0.5)% | (0.2)% |
| Currency | (4.1)% | (5.3)% | (3.1)% | (3.7)% |
| Divestitures | —% | (5.3)% | —% | (5.8)% |
| Total | (3.9)% | (12.2)% | (3.6)% | (9.7)% |
| **Total Company** |  |  |  |  |
| Organic | (6.0)% | 2.4% | (2.5)% | 3.1% |
| Currency | (2.2)% | (3.8)% | (1.6)% | (2.8)% |
| Divestitures | —% | (1.5)% | —% | (1.6)% |
| Total | (8.2)% | (2.9)% | (4.1)% | (1.3)% |
| **SEGMENT PROFIT AS A PERCENT OF NET SALES** |  |  |  |  |
| ID Solutions | 18.8% | 18.6% | 19.5% | 18.6% |
| Workplace Safety | 6.0% | 8.0% | 6.9% | 7.3% |
| Total | 15.3% | 15.9% | 16.2% | 15.7% |

### ID Solutions

IDS net sales decreased 9.7% in the three months ended April 30, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 8.2% and a decrease from foreign currency translation of 1.5%. The economic slowdown caused by the COVID-19 pandemic had a significant impact on organic sales trends during the quarter. Organic sales increased by 2.2% through the first two months of the quarter, then decreased by 27.6% in the month of April compared to the same periods in the prior year. Organic sales declined in all product lines in the quarter due to reduced demand from the economic slowdown caused by the COVID-19 pandemic.

IDS net sales decreased 4.3% in the nine months ended April 30, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 3.2% and a decrease from foreign currency translation of 1.1%. Organic sales declined in all product lines in the nine-month period due to reduced demand from the economic slowdown caused by the COVID-19 pandemic.

Organic sales in the Americas decreased in the high-single digits throughout the region in the three months ended April 30, 2020, compared to the same period in the prior year. By product line, product identification decreased in the low-single digits, and wire identification and safety and facility identification decreased in the mid-single digits due to the decrease in economic activity. As concerns grew regarding the availability of healthcare, a trend emerged in the second half of the quarter which was a significant decrease in elective surgeries and hospital admissions in the U.S. This resulted in a decline in organic sales in our healthcare identification product line in the low-teens in the three months ended April 30, 2020.

Organic sales in the Americas decreased in the low-single digits in the nine months ended April 30, 2020, compared to the same period in the prior year. Organic sales declined in the low-single digits in the United States, Canada and Brazil, and declined in the high-single digits in Mexico due to the economic slowdown caused by the COVID-19 pandemic. By product line, safety and facility identification increased organic sales in the low-single digits, product identification was flat and wire identification decreased in the low-single digits. The decrease in elective surgeries and hospital admissions occurring in the U.S. in the second half of the third quarter resulted in a mid-single digit organic sales decline in the healthcare identification product line in the nine months ended April 30, 2020.

Organic sales in Europe decreased in the low-teens in the three months ended April 30, 2020, compared to the same period in the prior year. The decline was broad-based throughout Europe except within a small group of businesses based in the Nordic region, which had organic sales growth of approximately 10% in the quarter. By product line, wire identification and product identification declined in the mid-single digits, and safety and facility identification declined in the mid-teens in the three-month period due to reduced demand from the economic slowdown caused by the COVID-19 pandemic.

Organic sales in Europe decreased in the high-single digits in the nine months ended April 30, 2020, compared to the same period in the prior year. The decline occurred throughout Europe except within a small group of businesses based in the Nordic region, which had organic sales growth in the mid-single digits in the nine-month period. By product line, wire identification and product identification declined in the low-single digits, and safety and facility identification declined in the high-single digits in the nine-month period due to reduced demand from the economic slowdown caused by the COVID-19 pandemic.

Organic sales in Asia grew modestly in the three months ended April 30, 2020, compared to the same period in the prior year. Organic sales growth was led by Japan and China with low-single digit growth, which was offset by an organic sales decline in India. Within China, Japan and the remainder of Southeast Asia, local governments began easing restrictions related to COVID-19 in March while India was under a government-ordered shutdown for the second half of the quarter. By product line, sales growth was led by wire identification and product identification, while safety and facility identification declined in the three-month period.

Organic sales in Asia decreased in the low-single digits in the nine months ended April 30, 2020, compared to the same period in the prior year. Organic sales declined in China and India, which was partially offset by growth in Japan and Southeast Asia. By product line, sales growth was led by wire identification and product identification, while safety and facility identification declined in the nine-month period.

Segment profit decreased to $36.4 million and increased to $119.5 million for the three and nine months ended April 30, 2020, respectively, compared to $39.9 million and $119.3 million for the same periods in the prior year. As a percentage of net sales, segment profit increased to 18.8% and 19.5% for the three and nine months ended April 30, 2020, respectively, from 18.6% for both periods in the prior year. The increase in segment profit as a percentage of sales was due to cost actions taken in response to the decline in revenue from the impact of the COVID-19 pandemic as well as reduced incentive compensation in both the three and nine-month periods.

### Workplace Safety

WPS net sales decreased 3.9% in the three months ended April 30, 2020, compared to the same period in the prior year, which consisted of organic sales growth of 0.2% and a decrease from foreign currency translation of 4.1%. The economic slowdown caused by the COVID-19 pandemic had a significant impact on organic sales trends during the quarter. Organic sales increased by 4.0% through the first two months of the quarter, then decreased by 7.5% in the month of April, compared to the same periods in the prior year. Sales through the digital channel grew approximately 12% while sales through the catalog channel declined in the low-single digits in the three-month period.

WPS net sales decreased 3.6% in the nine months ended April 30, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 0.5% and a decrease from foreign currency translation of 3.1%. Sales through the digital channel grew in the mid-single digits while sales through the catalog channel declined in the low-single digits in the nine-month period.

Organic sales in Europe increased in the low-single digits in the three months ended April 30, 2020, compared to the same period in the prior year. Digital channel sales increased in the high-single digits and catalog channel sales decreased slightly during the three-month period. Organic sales growth in the three-month period was primarily driven by increased sales of a variety of product categories related to mitigating the COVID-19 pandemic and increased sales in the Nordic region, which largely offset a decline in organic sales primarily in France due to temporary shutdowns during the quarter.

Organic sales in Europe increased modestly in the nine months ended April 30, 2020, compared to the same period in the prior year. Digital channel sales increased in the mid-single digits and catalog channel sales decreased in the low-single digits during the nine-month period. Organic sales growth in France, the UK, and the Nordic region was largely offset by a decline in sales in Germany due to reduced demand for industrial products.

Organic sales in the Americas decreased in the mid-teens in the three months ended April 30, 2020, compared to the same period in the prior year, which was driven by a mid-teens decline in both catalog channel sales and digital channel sales. Organic sales in the Americas decreased in the high-single digits in the nine months ended April 30, 2020, compared to the same period in the prior year. Digital channel sales declined in the mid-single digits and catalog channel sales declined in the high-single digits in the nine-month period. The target customer demographic of one particular business in WPS North America consists primarily of small companies, of which many were subject to government-ordered shutdowns during the second half of the quarter. This resulted in a significant decrease in sales orders which caused the majority of the decline in sales in the three- month period. In addition, the WPS North America business continued to experience a negative impact on sales from a digital platform that was implemented toward the end of fiscal 2018. The business transitioned to a new digital platform mid-way through fiscal 2019, however, sales have not yet returned to the level experienced prior to the initial platform change in fiscal 2018. Reduced demand from the economic slowdown caused by the COVID-19 pandemic resulted in additional digital sales declines in the three months ended April 30, 2020.

Organic sales in Australia increased more than 30% in the three months ended April 30, 2020, compared to the same period in the prior year. Digital channel sales increased more than 70% and catalog channel sales increased more than 20% during the three-month period. Australia was not impacted by the COVID-19 pandemic as severely as other countries in which we operate, and our Australian business generated increased sales of a variety of product categories related to mitigating the COVID-19 pandemic, including various types of personal protective equipment and other healthcare supplies. Organic sales increased nearly 10% in the nine months ended April 30, 2020, compared to the same period in the prior year, which was entirely due to the increase in organic sales in the current quarter.

Segment profit decreased to $4.4 million and $15.0 million for the three and nine months ended April 30, 2020, respectively, compared to $6.1 million and $16.3 million for the same periods in the prior year. As a percentage of net sales, segment profit decreased to 6.0% and 6.9% for the three and nine months ended April 30, 2020, respectively, compared to 8.0% and 7.3% for the same periods in the prior year. The decreases in segment profit were primarily due to additional costs incurred to further address our cost structure as a result of the COVID-19 pandemic, and the decline in profit resulting from the decrease in sales in the WPS North America business. These costs were partially offset by reduced incentive compensation.

#### Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At April 30, 2020, approximately 63% of the Company's cash and cash equivalents were held outside the United States. The Company's growth has historically been funded by a combination of cash provided by operating activities and debt financing. Based on management’s current expectations and currently available information, the Company believes that current cash on hand, cash flow from operating activities, and its borrowing capacity are sufficient to fund anticipated requirements for working capital, planned capital expenditures, common stock repurchases, scheduled debt repayments, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs and the impact of the COVID-19 pandemic could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

#### Cash Flows

Cash and cash equivalents were $238.9 million at April 30, 2020, a decrease of $40.2 million from July 31, 2019. The significant changes were as follows:

*(Dollars in thousands)*

| Net cash flow provided by (used in): | Nine months ended April 30, 2020 | 2019 |
| --- | ---: | ---: |
| Operating activities | $95,913 | $96,902 |
| Investing activities | (26,035) | (19,338) |
| Financing activities | (101,047) | (18,271) |
| Effect of exchange rate changes on cash | (9,023) | (2,288) |
| Net (decrease) increase in cash and cash equivalents | $(40,192) | $57,005 |

Net cash provided by operating activities was $95.9 million for the nine months ended April 30, 2020, compared to $96.9 million in the same period of the prior year. The decrease was primarily driven by a decrease in net income adjusted for non-cash items, which was partially offset by a decrease in cash used for working capital.

Net cash used in investing activities was $26.0 million for the nine months ended April 30, 2020, compared to $19.3 million in the same period of the prior year. The increase in cash used in investing activities was primarily driven by an increase in capital expenditures for the purchase of manufacturing equipment to support growth and improved productivity and facility upgrades in Europe, the United States, and Mexico, and to a lesser extent by investment purchases, primarily to fund deferred compensation plans.

Net cash used in financing activities was $101.0 million during the nine months ended April 30, 2020, compared to $18.3 million in the same period of the prior year. The change was primarily driven by $64.1 million of share repurchases, and to a lesser extent the decrease in cash proceeds from the exercise of stock options in the current nine-month period.

#### Debt

On May 13, 2010, the Company completed a private placement of €75.0 million aggregate principal amount of senior unsecured notes to accredited institutional investors. The €75.0 million of senior notes consisted of €30.0 million aggregate principal amount of 3.71% Series 2010-A Senior Notes, which were repaid during fiscal 2017, and €45.0 million aggregate principal amount of 4.24% Series 2010-A Senior Notes, due May 13, 2020, with interest payable on the notes semiannually. This private placement was exempt from the registration requirements of the Securities Act of 1933. The notes have been fully and unconditionally guaranteed on an unsecured basis by the Company’s domestic subsidiaries. The Company funded the remaining private placement principal payments due during the year ended July 31, 2020 with cash on hand.

#### Credit Facilities

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks that replaced and terminated the Company’s previous loan agreement that had been entered into on September 25, 2015. Under the new revolving loan agreement, the Company has the option to select either a base interest rate (based upon the higher of the federal funds rate plus one-half of 1% or the prime rate of the Bank of Montreal plus a margin based on the Company’s consolidated net leverage ratio), or the Eurocurrency interest rate (at the LIBOR rate plus a margin based on the Company’s consolidated net leverage ratio) plus 1%. At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million. As of April 30, 2020, there were no borrowings outstanding on the credit facility, and there were no outstanding balances during the nine months ended April 30, 2020. The Company had letters of credit outstanding under the loan agreement of $3.1 million as of April 30, 2020 and there was $196.9 million available for future borrowing, which can be increased to $396.9 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024, as such, any borrowing would be classified as long-term on the condensed consolidated balance sheets.

#### Covenant Compliance

The Company’s debt agreements require it to maintain certain financial covenants, including a ratio of debt to the trailing 12 months EBITDA, as defined in the debt agreements, of not more than a 3.25 to 1.0 ratio (leverage ratio) and the trailing 12 months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of April 30, 2020, the Company was in compliance with these financial covenants, with the leverage ratio, as defined by the agreements, equal to 0.0 to 1.0 and the interest expense coverage ratio equal to 77.7 to 1.0.

#### Off-Balance Sheet Arrangements

The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this and other Company filings. However, the following additional information is provided to assist those reviewing the Company’s financial statements.

Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.

Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.

#### Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

- Adverse impacts of the COVID-19 pandemic or other pandemics
- Brady's ability to compete effectively or to successfully execute its strategy
- Brady's ability to develop technologically advanced products that meet customer demands
- Difficulties in protecting websites, networks, and systems against security breaches
- Decreased demand for the Company's products
- Raw material and other cost increases
- Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
- Risks associated with the loss of key employees
- Divestitures, contingent liabilities from divestitures and the failure to identify, integrate, and grow acquired companies
- Litigation, including product liability claims
- Foreign currency fluctuations
- Changes in tax legislation and tax rates
- Potential write-offs of Brady's substantial intangible assets
- Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Part I, Item 1A of Brady's Annual Report on Form 10-K for the year ended July 31, 2019 and Part II, Item 1A of this Quarterly Report on Form 10-Q.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

## Market risk

As filed, 158 characters.

Refer to the Company’s Annual Report on Form 10-K for the year ended July 31, 2019. There has been no material change in this information since July 31, 2019.

## Controls and procedures

As filed, 1,804 characters.

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President and Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 3,427 characters.

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Brady's Annual Report on Form 10-K for the year ended July 31, 2019. There have been no material changes from the risk factors described in the 2019 Form 10-K, except for the addition of the following risk factor.

***Our results of operations have been and will in the future be adversely impacted by the COVID-19 pandemic or other pandemics, and the duration and extent to which it will impact our business and financial results remains uncertain.***

The global spread of COVID-19 has resulted in significant uncertainty and economic disruption. The extent to which our business and financial results are impacted will depend on numerous evolving factors which are uncertain and cannot be predicted, including: the duration and scope of the pandemic; governmental, business and individuals’ actions taken in response; the effect on our customers and customers’ demand for our services and products; the effect on our suppliers and disruptions to the global supply chain; our ability to sell and manufacture our products; disruptions to our operations resulting from the illness of any of our employees; restrictions or disruptions to transportation, including reduced availability of ground or air transport; the ability of our customers to pay for our products; and any closures of our facilities, our suppliers’ facilities, and our customers’ facilities. The effects of the COVID-19 pandemic have resulted and will result in additional expenses, lost or delayed revenue, and we have been experiencing disruptions to our business as we implement modifications to travel, work locations and cancellation of events, among other modifications. In addition, the deterioration of macroeconomic conditions may impact the proper functioning of financial and capital markets, foreign currency exchange rates, commodity and energy prices, and interest rates. Even after the COVID-19 pandemic subsides, we may continue to experience adverse impacts to our business and financial results due to any economic recession or depression that has occurred, and due to any major public health crises that may occur in the future.

Although our current accounting estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations and financial position. In particular, a number of estimates have been and will continue to be affected by the ongoing COVID-19 pandemic. The severity, magnitude and duration, as well as the economic consequences of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result, our accounting estimates and assumptions may change over time in response to COVID-19. Such changes could result in future impairments of goodwill, intangible assets, long-lived assets, incremental credit losses on accounts receivable, excess and obsolete inventory, or a decrease in the carrying amount of our deferred tax assets. Any of these events could amplify the other risks and uncertainties described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2019 and could have an adverse effect on our business and financial results.

Filed May 21, 2020.
Source: SEC EDGAR, the filing index for accession 0000746598-20-000048. Last ingested by Listed: Nov 9, 2026, 17:29 ET. No prices; not investment advice.
